Table 3 Incidence of PONV in the study and the control groups
Group A (n = 37) | Group B (n = 37) | p value | |
|---|---|---|---|
In the PACU | |||
PONV | 9 (24.3%) | 11 (29.7%) | 0.93 |
Asymptomic | 28 (75.7%) | 26 (70.3%) | |
PACU-6 h | |||
PONV | 8 (21.6%) | 8 (21.6%) | 0.90 |
Asymptomic | 29 (78.4%) | 29 (78.4%) | |
6 h–12 h | |||
PONV | 6 (16.2%) | 12 (32.4%) | 0.12 |
Asymptomic | 31 (83.8%) | 25 (67.6%) | |
12 h–24 h | |||
PONV | 3 (8.1%) | 5 (13.5%) | 0.46 |
Asymptomic | 34 (91.9%) | 32 (86.5%) | |
24 h–36 h | |||
PONV | 0 (0%) | 1 (2.7%) | 0.31 |
Asymptomic | 37 (100%) | 36 (97.3%) | |